Lane County releases COVID-19 vaccine clinic schedule for kids ages 5-11 - The Register-Guard

Suspected serial burglar detained pending trial - Albuquerque Journal

Copyright © 2021 Albuquerque Journal

Jesse Mascareno-Haidle

A district court judge has ordered a 19-year-old suspected of committing a string of nighttime home burglaries earlier this year to stay in jail pending trial after he was picked up for a new crime last week.

Jesse Mascareno-Haidle was arrested on Oct. 25 after students at Rio Grande High School told an officer that someone was breaking into cars in the parking lot. He is charged with burglary of a vehicle, resisting or evading an officer and attempting to commit a felony.

“I can’t think of conditions of release that the court could generate – short of placing him in custody – that would protect the community, that would ensure he’s not getting more charges,” said Judge Britt Baca-Miller at a hearing Monday.

Earlier this year Mascareno-Haidle was charged with two residential burglaries, auto theft, larceny and receiving stolen property, but police say he could be linked to as many as 80 other burglaries.

Prosecutors asked for Mascareno-Haidle to be kept in jail pending trial in the other cases, but that request was denied. He was ordered to wear a GPS monitor, adhere to a curfew and follow other conditions of release.

The teenager has become a poster child in the legal fight over pretrial detention and in May District Attorney Raúl Torrez took the case to the state Supreme Court, arguing that he should not have been released and his conduct is an “enormous risk to public safety.”

At Monday’s hearing Mascareno-Haidle’s attorney, Noah Gelb, argued that his client had followed the GPS restrictions and therefore would likely also follow any new conditions – such as if he was basically put on house arrest.

“Just as the conditions that were tailored in the last case did seem to reduce or eliminate the threat of nighttime residential burglaries – there haven’t been any of those – it seems like those conditions were working,” Gelb said. “If the court finds that there is an additional concern of daytime unlawful behavior then the question is are there specific conditions of release that can address that as well.”

However, the judge disagreed, saying that the GPS did not prevent Mascareno-Haidle from accruing more charges.

She said while the newest allegations against Mascareno-Haidle are not violent, she was going to take into consideration that in two previous orders judges found he was a danger to the community.

“I don’t want to say he is (flouting) the judicial rulings, but I think it’s something where these aren’t helping him not commit crimes,” Baca-Miller said. “It’s certainly not helping the community remain safe.”

Adblock test (Why?)

Suspected serial burglar detained pending trial - Albuquerque Journal
Read More

Elektros Inc. Secures Patent Pending For Revolutionary Battery Charging Technology - Yahoo Finance

Plans to begin marketing efforts of patent pending technology to major manufacturers of electric vehicles

SUNNY ISLES BEACH, Fla., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Elektros, Inc. (OTC: ELEK) announced today it has licensed a patent pending for a self-re-charging battery assembly and multi-port charging assembly. The patent pending pertains to a device application for United States Letters Patent was filed on October 27, 2021 in the United States Patent and Trademark Office.

Elektros will be targeting manufacturers of electric vehicles manufacturers, such as Waymo, Envoy, Lucid Motors, Revel, NIO, and Nikola with its patent pending technology, as well as manufacturers of alternative fuel vehicles. The Company plans to begin operations to design, develop and manufacture and sell fully electric sport utility vehicles and energy generation and storage systems.

Within the electric-based vehicle segment, there are three primary means of powertrain electrification which will differentiate various competitors to our planned electric sports utility vehicle, as well as potential users of our patent pending battery charging technology.

• Electric Vehicles are vehicles powered completely by a single on-board energy storage system (battery pack or fuel cell) which is refueled directly from an electricity source.

• Plug-in Hybrid Vehicles are vehicles powered by both a battery pack with an electric motor and an internal combustion engine which can be refueled both with traditional petroleum fuels for the engine and electricity for the battery pack. The internal combustion engine can either work in parallel with the electric motor to power the wheels, such as in a parallel plug-in hybrid vehicle, or be used only to recharge the battery, such as in a series plug-in hybrid vehicle like the Chevrolet Volt.

• Hybrid Electric Vehicles are vehicles powered by both a battery pack with an electric motor and an internal combustion engine but which can only be refueled with traditional petroleum fuels as the battery pack is charged via regenerative braking, such as used in a hybrid electric vehicle like the Toyota Prius.
  

Shlomo Bleier, CEO of Elektros, Inc. said, “This achievement is the first of many meaningful milestones that will add a secure foundation to build our sustainable competitive advantage. This IP allows us to protect our assets globally and advance towards commercialization.” Mr. Bleier continued, “We believe this technology could be a game changer for the electric vehicle industry. We plan to not only include it in our own designs, but aggressively market the technology to the major electric vehicle companies, as well.”

About Elektros Inc.

Elektros is an American Electric Vehicle company that innovates mobility solutions for consumers and businesses. The automotive landscape faces existential disruption over the next decade to reach carbon neutrality. Elektros addresses this paradigm shift with mobility technologies that support sustainability for a transformative user experience. Elektros aims to unveil a compelling and completely new Electric Vehicle experience to consumers beginning as early as 2023. The company plans a product unveiling in early 2022.

Cautionary Language Concerning Forward-Looking Statements

This release contains "forward-looking statements" that include information relating to future events and future financial and operating performance. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential," and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for Elektros, Inc's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in Elektros Inc's filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include statements regarding future sales, costs and market acceptance of products as well as regulatory actions at the State or Federal level. For a more detailed description of the risk factors and uncertainties affecting Elektros Inc. please refer to the Company's Securities and Exchange Commission filings, which are available at www.sec.gov. Elektros, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: Electros, Inc.

Investor Relations and Media Inquiries

Gabe Rodriguez

Email: erelationsgroup@gmail.com

Phone: (623) 261-9046

Adblock test (Why?)

Elektros Inc. Secures Patent Pending For Revolutionary Battery Charging Technology - Yahoo Finance
Read More

Pending Home Sales Dip In September – NMP - National Mortgage Professional Magazine

[unable to retrieve full-text content]

Pending Home Sales Dip In September – NMP  National Mortgage Professional Magazine
Pending Home Sales Dip In September – NMP - National Mortgage Professional Magazine
Read More

Pending home sales decelerate as mortgage rates rise - Mortgage Professional America

Read next: New home sales figures for September revealed

“Contract transactions slowed a bit in September and are showing signs of a calmer home price trend, as the market is running comfortably ahead of pre-pandemic activity,” said NAR chief economist Lawrence Yun. “It’s worth noting that there will be less inventory until the end of the year compared to the summer months, which happens nearly every year.”

Although housing supply stays low, Yun anticipates a turnaround in 2022.

“Rents have been mounting solidly of late, with falling rental vacancy rates,” he said. “This could lead to more renters seeking homeownership in order to avoid the rising inflation, so an increase in inventory will be welcomed.”

NAR projects home sales to have increased by 6.4% by year’s end before declining by 1.7% in 2022 due to rising mortgage rates. Yun also expects home prices to moderate to 2.8% next year after a double-digit price gain of 14.7% in 2021.

Adblock test (Why?)

Pending home sales decelerate as mortgage rates rise - Mortgage Professional America
Read More

Letter: The Most Important Legislation Pending in Congress - Arizona Daily Star

[unable to retrieve full-text content]

Letter: The Most Important Legislation Pending in Congress  Arizona Daily Star
Letter: The Most Important Legislation Pending in Congress - Arizona Daily Star
Read More

Q&A: What to know about the pending approval of a COVID-19 vaccine for kids ages 5-11 - Press Herald

On Tuesday and Wednesday, the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will meet to review data on COVID-19 vaccines for children ages 5-11.

If all goes as expected, U.S. CDC director Dr. Rochelle Walensky will then make a formal recommendation that would open eligibility to elementary school-age children.

Here’s what you need to know:

Q: Which vaccine will be offered to children?

A: The CDC is only considering the Pfizer vaccine for children at this time. Moderna and Johnson & Johnson have been studying the efficacy and safety of their vaccines for children but have not yet requested federal approval.

Q: Is Pfizer’s vaccine for children different than what has been offered to adults?

A: The Pfizer vaccine for 5-to-11-year-olds will still be a two-dose regimen, taken 21 days apart, but the children’s dose is smaller – about 10 micrograms, or one-third of the adult dose. Like adults, children will be considered fully vaccinated two weeks after their second shot.

Q: Is the vaccine safe for kids?

A: Overwhelmingly, yes. The U.S. Food and Drug Administration’s vaccine advisory committee voted 17-0 last week to recommend emergency use authorization, saying the benefits far outweigh any risks.

In clinical trials involving more than 3,000 children who received the vaccine, there were no serious adverse events. The most common reactions were similar to those associated with flu shots – pain at the injection site, fatigue and headaches – and those were mild.

Q: Why did it take so long?

A: Approving vaccines for smaller children was more challenging in part because Pfizer needed to find enough subjects for a robust clinical trial, one of the key steps in approving any vaccine. Additionally, getting the right size dose was the subject of much debate.

Q: If children are at low risk of developing serious symptoms from COVID-19, why is it important for them to be vaccinated?

A: It’s true that throughout the pandemic children who have gotten COVID-19 have generally had mild cases. But there are still risks, and still things we don’t know about the long-term effects of having COVID-19.

In the U.S., nearly 2 million children have been infected since the pandemic began, according to U.S. CDC data. Of those, 8,300 have been hospitalized and 94 have died. Although the number of deaths is small, it’s still in the top 10 causes of death for this age group.

The vaccine was found to be 91 percent effective in preventing symptomatic COVID-19 in 5-11-year-olds.

Beyond that, unvaccinated children can still be carriers and vectors of the virus, keeping it alive and risking infecting others in their family, including older relatives or those with immunodeficiencies. Vaccinations dramatically reduce the risk of transmitting the disease.

And from a practical standpoint, having children vaccinated will help normalize school. Vaccinated children do not need to be quarantined if they come into contact with someone who tests positive for COVID-19.

If enough children are vaccinated, mask mandates in schools could also be lifted.

Q: How soon will shots be available?

A: States, including Maine, have been preparing for months for the likelihood that child vaccines would be approved. Even though vaccines cannot be administered until the CDC authorizes them, states can start ordering doses. That means vaccinations could begin within a day of CDC authorization.

Q: Where can parents get their children vaccinated?

A: The primary vaccination sites for children are expected to be school-based clinics, pediatricians’ offices, and some retail pharmacies.

Health care providers already have partnered with schools to set up clinics, and the vaccine is going to be made available in smaller batches to deliver to doctors’ offices. Unlike the early rollout of the vaccine when Pfizer’s vaccine needed ultra-cold storage, the children’s dose can be stored in a refrigerator for 10 weeks.

Q: What will it cost?

A: As has been the case with vaccines for adults, there is no cost for parents to vaccinate their children and no insurance requirements.

Q: Will the COVID-19 vaccine be a requirement to attend school?

A: Currently, no, although it’s possible that could change. Maine law already requires public school students to complete a host of vaccinations, for things like chickenpox and measles, and also no longer allows parents to opt their children out of vaccinations for religious or philosophical reasons. An effort to overturn that law change failed overwhelmingly in a 2020 referendum.

Comments are not available on this story.

« Previous

Gideon campaign still sitting on $10 million from 2020 bid for U.S. Senate

Next »

Maine deer cutters scramble to keep up with surge in hunters

filed under:

Related Stories

Latest Articles

Adblock test (Why?)

Q&A: What to know about the pending approval of a COVID-19 vaccine for kids ages 5-11 - Press Herald
Read More